Solara Active Pharma Sciences has clarified that Company has made all the required disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that, in its opinion, would have a bearing on the price/volume behaviour in the scrip.
The above information is a part of company’s filings submitted to BSE.